Aikawa S, Hashimoto T, Kano K, Aoki J (2015) Lysophosphatidic acid as a lipid mediator with multiple biological actions. J Biochem 157:81–89

CAS  PubMed  Google Scholar 

Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988

CAS  PubMed  PubMed Central  Google Scholar 

Aoki J, Inoue A, Okudaira S (2008) Two pathway for lysophosphatidic acid production. Biochim Biophys Acta 1781:513–518

CAS  PubMed  Google Scholar 

Arang N, Gutking JS (2020) G protein-coupled receptors and heterotrimeric G proteins as cancer drivers. FEBS Lett 594:4201–4232

CAS  PubMed  PubMed Central  Google Scholar 

Balogh A, Shimizu Y, Lee SC, Norman DD, Gangwar R, Bavaria M, Moon C, Shukla P, Rao R, Ray R, Naren AP, Banerje S, Miller DD, Balazs L, Pelus L, Tigyi G (2015) The autotaxin-LPA2 GPCR axis is modulated by γ-irradiation and facilitates DNA damage repair. Cell Signal 27:1751–1762

CAS  PubMed  PubMed Central  Google Scholar 

Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737

CAS  PubMed  Google Scholar 

Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, Hu T, Jiang L, Li J (2016) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett 370:153–164

CAS  PubMed  Google Scholar 

Choi JW, Lee CW, Chun J (2008) Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochim Biophys Act 1781:531–539

CAS  Google Scholar 

Dong Y, Hirane M, Araki M, Fukushima N, Honoki K, Tsujiuchi T (2014) Lysophosphatidic acid receptor-5 regulates cells motile and invasive avtivities of human sarcoma cell lines. Mol Cell Biochem 393:17–22

CAS  PubMed  Google Scholar 

Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH (1993) The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291:677–680

CAS  PubMed  PubMed Central  Google Scholar 

Fang X, Schummer M, Mao M, Yu S, Tabassam FH, Swaby R, Hasegawa Y, Tanyi JL, LaPushin R, Eder A, Jaffe R, Erickson J, Mills GB (2002) Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim Biophys Acta 1582:257–264

CAS  PubMed  Google Scholar 

Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Takakura Y (2009) Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 34:1381–1386

CAS  PubMed  Google Scholar 

Fujita T, Miyamoto S, Onoyama I, Sonoda K, Mekada E, Nakano H (2003) Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett 192:161–169

CAS  PubMed  Google Scholar 

Fukui R, Tanabe E, Kitayoshi M, Yoshikawa K, Fukushima N, Tsujiuchi T (2012) Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells. Tumor Biol 33:1899–1905

CAS  Google Scholar 

Fukushima K, Takahashi K, Yamasaki E, Onishi Y, Fukushima N, Honoki K, Tsujiuchi T (2017) Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells. Exp Cell Res 352:139–145

CAS  PubMed  Google Scholar 

Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MAV, Lu Y, Fang X, Tsutsui S, Siddik ZH, Bast RC Jr, Mills GB (1999) Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin Cancer Res 5:4308–4318

CAS  PubMed  Google Scholar 

Furuta D, Yamane M, Tsujiuchi T, Moriyama R, Fukushima N (2012) Lysophosphatidic acid induces neurite branch formation through LPA3. Mol Cell Neurosci 50:21–34

CAS  PubMed  Google Scholar 

Geraldo LHM, Spohr TCLS, Amaral RFD, Fonseca ACCD, Garcia C, Mendes FA, Freitas C, dosSantos MH, Lima FRS (2021) Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Trandsuct Target Ther 6:45

CAS  Google Scholar 

Gerrard JM, Kingdom SE, Peterson DA, Peller J, Krantz KE, White JG (1979) Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium. Am J Pathol 96:423–438

CAS  PubMed  PubMed Central  Google Scholar 

Hamilton G, Rath BA (2014) A short update on cancer chemoresistance. Wine Med Wochenschr 164:456–460

Google Scholar 

Hayashi M, Okabe K, Kato K, Okumura M, Fukui R, Fukushima N, Tsujiuchi T (2012) Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett 326:91–96

Google Scholar 

Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313–323

CAS  PubMed  Google Scholar 

Honoki K, Fujii H, Kubo A, Kido A, Mori T, Tanaka Y, Tsujiuchi T (2010) Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol Rep 24:501–505

CAS  PubMed  Google Scholar 

Hu Y-L, Tee M-K, Goetzl EJ, Auersperg N, Mills GB, Ferrara N, Jaffe RB (2001) Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst 93:762–768

CAS  PubMed  Google Scholar 

Huang RX, Zhou PK (2020) DNA damage response signaling pathways and target for radiotherapy sensitization in cancer. Signal Transduct Target Ther 5:60

CAS  PubMed  PubMed Central  Google Scholar 

Huang W-H, Chang M-C, Tsai K-S, Hung M-C, Chen H-L, Hung S-C (2013) Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene 32:4343–4354

CAS  PubMed  Google Scholar 

Insel PA, Zhang L, Murray F, Yokouchi H, Zambon AC (2012) Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger. Acta Physiol 204:277–287

CAS  Google Scholar 

Ishii S, Noguchi K, Yanagida K (2009) Non-edg family lysophsphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 89:57–65

CAS  PubMed  Google Scholar 

Ishii S, Hirane M, Fukushima K, Tomimatsu A, Fukushima N, Tsujiuchi T (2015) Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells. Biochem Biophys Res Commun 461:59–64

CAS  PubMed  Google Scholar 

Jeon ES, Moon HJ, Lee MJ, Song HY, Kim YM, Cho M, Suh D-S, Yoon M-S, Chang CL, Jung JS, Kim JH (2008) Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells 26:789–797

CAS  PubMed  Google Scholar 

Jeon ES, Heo SC, Lee IH, Choi YJ, Park JH, Choi KU, Park DY, Suh DS, Yoon MS, Kim JH (2010) Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1α from human mesenchymal stem cells. Exp Mol Med 42:280–293

CAS  PubMed  PubMed Central  Google Scholar 

Jinno N, Yoshida M, Hayshi K, Naitho I, Hori Y, Natsume M, Kato A, Kachi K, Asano G, Atsuta N, Sahashi H, Kataoka H (2021) Autotaxin in ascites projotes peritoneal dissemination in pancreatic cancer. Cancer Sci 112:668–678

CAS  PubMed  Google Scholar 

Kathawala RJ, Gupta P, Ashby CR Jr, Chen Z-S (2015) The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat 18:1–17

PubMed  Google Scholar 

Kato K, Fukui R, Okabe K, Tanabe E, Kitayoshi M, Fukushima N, Tsujiuchi T (2012) Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloptoteinase-2. Biochem Biophys Res Commun 417:790–793

CAS  PubMed  Google Scholar 

Kessenbrock K, PlaksV, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67

CAS  PubMed  PubMed Central  Google Scholar 

Kitayama J, Shida D, Sako A, Ishikawa M, Hama K, Aoki J, Arai H, Nagawa H (2004) Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma. Breast Cancer Res 6:R640–R646

CAS  PubMed  PubMed Central  Google Scholar 

Komachi M, Tomura H, Malchinkhuu E, Tobo M, Mogi C, Yamada T, Kimura T, Kuwabara A, Ohta H, Im D-S, Kurose H, Takeyoshi I, Sato K, Okajima F (2009) LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Carcinogenesis 30:457–465